Tumor protein P53 (TP53) plays an important role in suppressing the growth of tumors. Mutations in the gene for TP53 can have ...

An international team of medical researchers has developed a protein-based risk score for hip fracture using an aptamer-based ...

Aptamer Group plc (AIM: APTA), the developer of novel Optimer® binders to enable innovation in the life sciences industry, ...

Reference: Kong L, Meng F, Zhou P, et al. An engineered DNA aptamer-based PROTAC for precise therapy of p53-R175H hotspot ...

London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Aptamer Group has announced further agreements with a combined value of up to £275,000 including three of the top ten global ...

In this Q&A, senior leaders at Caris Life Sciences discuss how the company is advancing precision medicine by integrating ...

Background and Highlights: Universal aptamer has been selected for influenza virus, including H5N1 Binding affinity of influenza aptamer is better than aptamer used for SARS-CoV-2, which has ...

Optimer binders will be developed for use in a cervical cancer blood test. Agreement for up to £465,000 signed for Optimer development.

York-headquartered life sciences company Aptamer Group has signed an agreement valued at up to £465,00o with a pharmaceutical company focused on women's health.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...